Navigation Links
Kremers Urban Pharmaceuticals Inc. Announces Lipitor® Settlement Agreement
Date:11/18/2011

PRINCETON, N.J., Nov. 18, 2011 /PRNewswire/ -- Kremers Urban Pharmaceuticals Inc. today announced that it has entered into a settlement agreement which will resolve litigation related to Lipitor® Tablets, 10 mg, 20 mg, 40 mg, and 80 mg, known generically as Atorvastatin Calcium tablets.  

The terms of the agreement are confidential, and the agreement itself is subject to review by the U.S. Department of Justice and the Federal Trade Commission.

About Kremers Urban

Kremers Urban Pharmaceuticals Inc., a specialty generic drug manufacturer and subsidiary of Belgium-based UCB, is a pioneer in developing generic versions of pharmaceutical products that have a "high barrier to entry." The Company is moving to the forefront of delivering the tough solutions necessary to get complex products into the market. To learn more visit www.kremersurban.com.

For More Information Contact:

France Nivelle, Global Communications
+32 2 559 9178; france.nivelle@ucb.com

Antje Witte, Investor Relations
+32 2 559 9414; antje.witte@ucb.com


'/>"/>
SOURCE Kremers Urban Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Kremers Urban Pharmaceuticals Inc. Settles Concerta® Patent Litigation
2. Study Sheds Light on Young Suburban Heroin Users
3. NxStage Medical Founder and CEO Jeffrey Burbank Honored With Mass High Tech All-Star Award
4. CVS Caremark Showcases Workplace and Marketplace Diversity at 2011 National Urban League Conference
5. Surgical Care Affiliates Announces Agreement With Suburban Outpatient Surgery Center
6. NxStage Founder and CEO Jeffrey Burbank Named Ernst & Young Entrepreneur of the Year® 2011 New England Award Winner
7. Teach For America and the Amgen Foundation Renew Partnership to Improve Math and Science Education in Urban and Rural Schools
8. American Heart Association Rapid Access Journal Report: Implanted Monitor Accurately Detects Heart Rhythm Disturbances
9. Bionovos MF101 Shows Statistically Significant Improvement in Sleep Disturbance from Hot Flashes
10. Merrimack Pharmaceuticals Initiates Enrollment in Phase 2 Study of MM-121 in Combination with Erlotinib in Three Groups of Patients with Non-Small Cell Lung Cancer
11. Avanir Pharmaceuticals Announces EMA Acceptance of Marketing Authorization Application for NUEDEXTA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/4/2017)...  South Korean-based healthcare product Development Company I.M. Lab ... Kickstarter. The device will educate the user about ,proper, ... efficiency compared to the dated and pricey CPR training ... of the compression for a more informed CPR training. ... raise $5,000. cprCUBE ...
(Date:10/4/2017)... 4, 2017 OBP Medical , ... medical devices, today announced regulatory approval from ... (or Agência Nacional de Vigilância Sanitária (ANVISA)) to ... surgical retractor with integrated LED light source and ... and exposure of a tissue pocket or cavity ...
(Date:10/2/2017)... 2, 2017  Eli Lilly and Company (NYSE: ... the third quarter of 2017 on Tuesday, October 24, ... that day with the investment community and media to ... conference call will begin at 9 a.m. Eastern time. ... live webcast of the conference call through a link ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... ... The Visiting Nurse Association (VNA) of Somerset Hills is proud to host ... items from across the nation, this holiday-themed event will raise funds and awareness for ... The boutique will be open Saturday, November 4 (10:00 a.m. – 5:00 p.m.) ...
(Date:10/13/2017)... ... 13, 2017 , ... Coveros, a leader in agile coaching ... contract by the Center for Medicare and Medicaid Services (CMS). The Enterprise Agile ... of Agile methodologies in a consistent and high value manner across CMS programs. ...
(Date:10/12/2017)... ... , ... Planet Fitness, one of the largest and fastest growing franchisors and ... flagship location in Covington, LA at 401 N. U.S. Highway 190, in January of ... Depot in the Holiday Square shopping center. Its location allows it to serve both ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the ... to develop to enable prevention of a major side effect of chemotherapy in ... in pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... been named one of Michigan’s 2017 Best and Brightest in Wellness® by Best ... in Wellness® awards program on Friday, Oct. 20 from 7:30 a.m. to 2 ...
Breaking Medicine News(10 mins):